MarketWatch
  • Markets
  • App
    • iOS
    • Android
    • Desktop
  • How To
    • Hindi
  • University
  • Blog
  • Exchanges
    • MCX
      • Live MCX Price
    • NSE
  • About
    • Partnerships
    • Journey
  • Agreements
    • Privacy Policy
    • Terms of Use
Select Page

Sebi delays implementation of new norms for proxy advisors due to Covid Business Standard

by abhinav | Aug 27, 2020 | Analysis

The new framework, which was to come into effect from September 1, will now be applicable from January 1, 2021 Read More

reported by BS Reporter at Business Standard

RBI did not print even one Rs 2,000 note in 2019 Hindustan Times

by abhinav | Aug 25, 2020 | Analysis by Rahul

The number of Rs 2,000 notes peaked at 3.36 billion units (or pieces) in 2017-18. This number dropped to 3.29 billion in 2018-19. It has fallen again to 2.73 billion in 2019-20 Read More

reported by Roshan Kishore and Rajeev Jayaswal at Hindustan Times

Kiran Mazumdar Shaw of Biocon tests positive for COVID Moneycontrol

by abhinav | Aug 18, 2020 | Analysis

Biocon is one of the companies looking to create a vaccine to fight COVID-19 Read More

reported by at Moneycontrol

USFDA clears simple saliva test for faster detection of Covid Times of India

by abhinav | Aug 16, 2020 | Analysis

US News: The US health watchdog has authorised the emergency use of a new and expensive saliva based laboratory diagnostic test for Covid-19 that could be a ga Read More

reported by PTI at The Times of India

Shree Cement stock punished for relatively poor cost control visvis peers – Livemint

by abhinav | Aug 11, 2020 | Analysis

Operating cost on a per tonne basis for the company rose 7% sequentially.This could have been a fallout of the rise in company’s freight cost/tonne, which rose nearly 10% quarter-on-quarter Read More

reported by Harsha Jethmalani at Livemint

Cadila Health shares gain as Zydus drug receives nod to conduct clinical trials to treat COVID Moneycontrol.com

by abhinav | Jul 28, 2020 | Analysis

Zydus received approval from COFEPRIS to conduct clinical trials in Mexico with Pegylated Interferon alpha-2b to treat novel Coronavirus. Read More

reported by at Moneycontrol

« Older Entries
Next Entries »

Recent Posts

  • JPMorgan downgrades Indian IT sector but bullish on these 4 IT stocks | Mint – Mint
  • PhysicsWallah raises $100 million from Westbridge, GSV Ventures, joins unicorn club – Moneycontrol
  • Gold loan platform Rupeek lays off over 180 of its employees – Moneycontrol
  • JPMorgan Sees 60% Upside In Paytm’s Beaten-Down Stock. Here’s Why… – BQ Prime
  • Policybazaar tanks 10% as CEO Yashish Dahiya plans 3.77 mn share sale – Business Standard

Recent Comments

  • 22 live with parents on CrudeOil Feb Futures: Quant-Look 21 Jan ’19

Archives

  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • November 2019
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • June 2019
  • May 2019
  • April 2019
  • March 2019
  • February 2019
  • January 2019
  • December 2018

Categories

  • Analysis
  • Analysis by Rahul
  • Blog
  • Chart Strategy
  • Market-Watch Staff
  • News
  • Uncategorized
  • what-is

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org
All rights reserved with Umun Tech, New Delhi